Error is an inherent component and an intrinsic by-productof every activity in which humans are involved. This ten-dency to err is philosophically perhaps one of the definingtraits that characterize us as human beings. Transfusionerrors probably existed once blood transfusion became anessential component of medical treatment. However, thesystematic acknowledgement, recognition and analysis ofthese errors are certainly a much more recent phenomenon.According to an Institute of Medicine (IOM) reportreleased in 1999 [1], medical errors are one of the leadingcause of death in the US and have caused an estimated44 000–98 000 deaths per year, which is soberingly morethan the motor vehicle accident death rate of 43 458 forthat particular year.Errors and adverse events carry a high financial burden.The Agency of Healthcare Research and Quality (AHRQ)estimated that the cost of medical errors resulting inadverse events is approximately $37AE6 billion per year, and$17 billion of those costs are preventable [1]. Significantly,the AHRQ has reported that medical errors are not onlybecause of medication errors but can result from bloodtransfusion errors, misdiagnosis, misinterpretation of labo-ratory results with incorrect therapy, equipment failure,hospital acquired infections or misinterpretation medicalorders.Looking specifically at transfusion mortality, Schmidtreviewed 69 records of deaths labelled as transfusion mor-tality and concluded that 31 (44AE9%) were directly attribut-able to transfusion, of which 25 were due to red cellincompatibilities and discrepancies [2]. Myhre reviewed113 records fatalities reported to the Food and DrugAdministration (FDA) as a sequelae of blood or blood prod-uct transfusion from 3 April 1976 to 31 December 1979 [3].Thirty-three fatalities were due to post-transfusion hepati-tis, and three involved plasmapheresis or leucopheresisdonors. The remaining 77 cases were of three categories:the vast majority were preventable errors: 47 cases (61%)were due to ‘‘clerical errors’’ such as drawing the wrongblood specimen or giving the wrong unit of blood to thepatient; 8 cases consisted of genuine errors that occurred inthe laboratory and 22 miscellaneous cases.Many other recent reports exist with the majority retro-spective and involving registry data (e.g. reporting to theFDA). Honig and Bove listed 70 fatalities, 38 of which weredue to transfusion errors [4]. Camp and Monaghan studied126 FDA reports from 1976 through 1980. They found that64 reactions that were due to simple clerical errors, such asgiving the blood to the wrong patient [5].In a landmark paper, Sazama and colleagues studiedtransfusion-related deaths reported to the US FDA for10 years and identified 131 fatal ABO incompatible trans-fusions. The study showed that the most frequent errorleading to a fatal outcome was administration to someoneother than the intended recipient [6]. Records of transfusionerrors in the New York State for the past 10 years (Linden)showed that erroneous blood administration was observedin 1 out of 19 000 RBC units administered. Half of theseevents occurred outside the blood bank (administration tothe wrong recipient, phlebotomy errors, testing of thewrong specimen, transcription errors and issuance of thewrong unit) with 15% of cases involving multiple errors [7].McClelland and Phillips conducted a study and analysedthe data from haematology laboratories in the UK for theyears 1990 and 1991. They sent a questionnaire to 400 lab-oratories involved in blood transfusion and only 245 (61%)submitted their reply. The reports included data on deaths,morbidity and near misses. One-third of the laboratoriesreported incidents in which the patient received a wrongunit of blood [8].
Read full abstract